Oramed Pharmaceuticals Inc. 13D and 13G filings for Scilex Holding Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-08 4:15 pm Purchase |
2025-03-31 | 13G | Scilex Holding Company SCLX |
ORAMED PHARMACEUTICALS INC. ORMP |
732,717 9.900% |
289,860 (+65.45%) |
Filing |
| 2025-01-17 4:15 pm Purchase |
2025-01-13 | 13G | Scilex Holding Company SCLX |
ORAMED PHARMACEUTICALS INC. ORMP |
442,857 6.200% |
442,857 (New Position) |
Filing |